{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:48:40Z","timestamp":1791416920975,"version":"4.3.3"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,7]]},"DOI":"10.1212\/wnl.51.1.120","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:34:42Z","timestamp":1336916082000},"page":"120-124","source":"Crossref","is-referenced-by-count":277,"title":["A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension"],"prefix":"10.1212","volume":"51","author":[{"given":"R. A.","family":"Wright","sequence":"first","affiliation":[{"name":"From the Department of Neurology (Drs. Wright, Opfer-Gehrking, and Low), Mayo Clinic, Rochester, MN; Department of Neurology (Drs. Kaufmann and Perera), Mount Sinai Medical Center, New York, NY; and Roberts Pharmaceuticals Corporation (Drs. McElligott and Sheng), Eatontown, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Wright, Opfer-Gehrking, and Low), Mayo Clinic, Rochester, MN; Department of Neurology (Drs. Kaufmann and Perera), Mount Sinai Medical Center, New York, NY; and Roberts Pharmaceuticals Corporation (Drs. McElligott and Sheng), Eatontown, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Perera","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Wright, Opfer-Gehrking, and Low), Mayo Clinic, Rochester, MN; Department of Neurology (Drs. Kaufmann and Perera), Mount Sinai Medical Center, New York, NY; and Roberts Pharmaceuticals Corporation (Drs. McElligott and Sheng), Eatontown, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. L.","family":"Opfer-Gehrking","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Wright, Opfer-Gehrking, and Low), Mayo Clinic, Rochester, MN; Department of Neurology (Drs. Kaufmann and Perera), Mount Sinai Medical Center, New York, NY; and Roberts Pharmaceuticals Corporation (Drs. McElligott and Sheng), Eatontown, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"McElligott","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Wright, Opfer-Gehrking, and Low), Mayo Clinic, Rochester, MN; Department of Neurology (Drs. Kaufmann and Perera), Mount Sinai Medical Center, New York, NY; and Roberts Pharmaceuticals Corporation (Drs. McElligott and Sheng), Eatontown, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. N.","family":"Sheng","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Wright, Opfer-Gehrking, and Low), Mayo Clinic, Rochester, MN; Department of Neurology (Drs. Kaufmann and Perera), Mount Sinai Medical Center, New York, NY; and Roberts Pharmaceuticals Corporation (Drs. McElligott and Sheng), Eatontown, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Low","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Wright, Opfer-Gehrking, and Low), Mayo Clinic, Rochester, MN; Department of Neurology (Drs. Kaufmann and Perera), Mount Sinai Medical Center, New York, NY; and Roberts Pharmaceuticals Corporation (Drs. McElligott and Sheng), Eatontown, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"Fealey RD Robertson D. Management of orthostatic hypotension. In: Low PA ed. Clinical autonomic disorders: evaluation and management. Boston: Little Brown 1993:731-743."},{"key":"e_1_3_1_3_2","unstructured":"Bannister R. Multiple system atrophy and pure autonomicfailure. In: Low PA ed. Clinical autonomic disorders: evaluation and management. Boston: Little Brown 1993:517-526."},{"key":"e_1_3_1_4_2","first-page":"289","volume":"22","year":"1970","unstructured":"Thomas JE, Schirger A. Idiopathic orthostatic hypotension. A study of its natural history in 57 neurologically affected persons. Arch Neurol 1970;22:289-293.","journal-title":"Neurol"},{"key":"e_1_3_1_5_2","first-page":"692","volume":"22","year":"1987","unstructured":"Cohen J, Low P, Fealey R, Sheps S, Jiang N-S. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol 1987;22:692-699.","journal-title":"Neurol"},{"key":"e_1_3_1_6_2","unstructured":"Low PA McLeod JG. The autonomic neuropathies. In: Low PA ed. Clinical autonomic disorders: evaluation and management. Boston: Little Brown 1993:395-421."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198938050-00004"},{"key":"e_1_3_1_8_2","first-page":"586","volume":"39","year":"1986","unstructured":"Zachariah PK, Bloedow DC, Moyer TP, Sheps SG, Schirger A, Fealey RD. Pharmacodynamics of midodrine, an antihypotensive agent. Clin Pharmacol Ther 1986;39:586-591.","journal-title":"Ther"},{"key":"e_1_3_1_9_2","first-page":"423","volume":"16","unstructured":"Thulesius O, Gjores JE, Berlin E. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins. Eur J Clin Pharmacol 1979;16:423-424.","journal-title":"ST"},{"key":"e_1_3_1_10_2","first-page":"447","volume":"37","year":"1987","unstructured":"Grobecker H, Kees F, Linden M, Schrader E, Welte S. Studies on the bioavailability of midodrine and alpha-2, 5-dimethoxyphenyl-beta-aminoethanol-hydrochloride. Arzneimittelforschung 1987;37:447-450.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_1_11_2","first-page":"1037","volume":"144","year":"1984","unstructured":"Schatz IJ. Orthostatic hypotension: II. Clinical diagnosis, testing and treatment. Arch Intern Med 1984;144:1037-1041.","journal-title":"Med"},{"key":"e_1_3_1_12_2","first-page":"2145","volume":"26","unstructured":"Pittner H, Stormann H, Enzenhofer R. Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059. Arzneimittelforschung 1976;26:2145-2154.","journal-title":"ST"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90230-M"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.6.951"},{"key":"e_1_3_1_15_2","unstructured":"Low PA. Laboratory evaluation of autonomic failure. In: Low PA ed. Clinical autonomic disorders: evaluation and management. Boston: Little Brown 1993:169-195."},{"key":"e_1_3_1_16_2","unstructured":"Robertson D Davis TL. Recent advances in the treatment of orthostatic hypotension. Neurology 1995;45(suppl 5):S26-S32."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.1.120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:59:17Z","timestamp":1711551557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.1.120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1212\/WNL.51.1.120"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.1.120","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}